Head and Neck Cancer Trial, Recruiting NCT05774483 Sponsor: Tata Memorial Hospital Condition: Head and Neck Cancer
Back to Head And Neck Cancer

Head and Neck Cancer Trial, Recruiting

NCT05774483
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are older than 18 years of age
  • People who have been confirmed by biopsy to have invasive squamous cell carcinoma (a type of cancer) located on the tongue or the inner cheek lining (buccal mucosa)
  • People whose tumour is classified as T1 or T2 in size, according to a standard cancer staging system (the AJCC TNM 8th edition)
  • People whose cancer has not spread to the lymph nodes, based on physical examination and imaging
  • People whose tumour can be removed through the mouth, without the need for external surgery
  • People who have not yet received any treatment for this cancer
  • People who do not have cancer at any other location in the body

Who may not be able to join:

  • People who have had previous surgery in the head or neck area
  • People whose lesion is located on the upper gum (upper alveolus) or the roof of the mouth (palate)
  • People who have large areas of mixed-appearance leukoplakia (white patches in the mouth) or other precancerous conditions
  • People who have had a previous cancer in the head or neck region
  • People whose treatment would require a complex reconstruction procedure using tissue transferred from another part of the body (known as a free flap reconstruction)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Richa Vaish, MS, M.Ch, Tata Memorial Hospital

Phone: 02224177000

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Tata Memorial Hospital
Registry
ClinicalTrials.gov
Start date
16 April 2025
Est. completion
1 April 2032

Where this trial is recruiting

🇮🇳 India

Primary endpoints

Overall survival

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov